Elimination of free immunoglobulin light chains with the use of EMic2 selective filters was carried out in 12 patients with monoclonal gammopathies and high production of free immunoglobulin light chains. We showed that extracorporeal detoxification for direct removal of excessive free immunoglobulin light chains from the circulation is advisable for these patients, irrespective of the presence and severity of renal insufficiency. Rapid reduction or elimination of free light chains of immunoglobulins in the course of selective extracorporeal elimination helps to prevent the development of irreversible renal failure and to perform adequate antitumor therapy.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Lubimova NV, Turko TA, Votyakova OM, Kushlinskii NE. Serum immunoglobulin free light chains in patients with monoclonal gammapathies. Bull. Exp. Biol. Med. 2012;153(2):249-254.
Turko TA, Lyubimova NV, Ageeva TV, Votyakova OM. Free light chains of immunoglobulins in multiple myeloma. Klin. Lab. Diagnost. 2010(9):29. Russian.
Clark WF, Stewart AK, Rock GA, Sternbach M, Sutton DM, Barrett BJ, Heidenheim AP, Garg AX, Churchill DN; Canadian Apheresis Group. Plasma exchange when myeloma presents as acute renal failure: a randomized controlled trial. Ann. Intern. Med. 2005;143(11):777-784.
Hutchison CA, Cockwell P, Reid S, Chandler K, Mead GP, Harrison J, Hattersley J, Evans ND, Chappell MJ, Cook M, Goehl H, Storr M, Bradwell AR. Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma: in vitro and in vivo studies. J. Am. Soc. Nephrol. 2007;18(3):886-895.
Iggo N, Winearls CG, Davies DR. The development of castnephropathy in multiple myeloma. QJM. 1997;90(11):653-656.
Knudsen LM, Hjorth M, Hippe E. Renal failure in multiple myeloma: Reversibility and impact on prognosis. Eur. J. Haematol. 2000;65(3):175-181.
Kyle RA, Gertz MA, Witzig TE, Lust JA, Lacy MQ, Dispenzieri A, Fonseca R, Rajkumar SV, Offord JR, Larson DR, Plevak ME, Therneau TM, Greipp PR. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin. Proc. 2003;78(1):21-33.
Leung N, Gertz MA, Zeldenrust SR, Rajkumar SV, Dispenzieri A, Fervenza FC, Kumar S, Lacy MQ, Lust JA, Greipp PR, Witzig TE, Hayman SR, Russell SJ, Kyle RA, Winters JL. Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains. Kidney Int. 2008;73(11):1282-1288.
Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, Kumar S, Hillengass J, Kastritis E, Richardson P, Landgren O, Paiva B, Dispenzieri A, Weiss B, LeLeu X, Zweegman S, Lonial S, Rosinol L, Zamagni E, Jagannath S, Sezer O, Kristinsson SY, Caers J, Usmani SZ, Lahuerta JJ, Johnsen HE, Beksac M, Cavo M, Goldschmidt H, Terpos E, Kyle RA, Anderson KC, Durie BG, Miguel JF. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15(12):e538-e548.
Sakhuja V, Jha V, Varma S, Joshi K, Gupta KL, Sud K, Kohli HS. Renal involvement in multiple myeloma: a 10-year study. Ren. Fail. 2000;22(4):465-477.
Zucchelli P, Pasquali S, Cagnoli L, Ferrari G. Controlled plasma exchange trial in acute renal failure due to multiple myeloma. Kidney Int. 1988;33(6):1175-1180.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 163, No. 4, pp. 494-498, April, 2017
Rights and permissions
About this article
Cite this article
Lyubimova, N.V., Timofeeva, Y.S., Gromova, E.G. et al. Free Immunoglobulin Light Chains as Criteria of Extracorporeal Hemocorrection in Patients with Monoclonal Gammopathies. Bull Exp Biol Med 163, 493–496 (2017). https://doi.org/10.1007/s10517-017-3836-5
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-017-3836-5